In the United States, Human papillomavirus (HPV) causes around 70% of head and neck cancers, making it the most common cancer caused by the virus. The incidence rates are climbing each year, and what ...

Researchers from the University of Michigan Health Rogel Cancer Center have created a urine-based test that detects pieces of DNA fragments released by head and neck tumors. The test could potentially ...

But what if a mouthwash-based test to detect biomarkers can help physicians predict disease recurrence in head and neck cancer patients? That futuristic scenario seems closer to reality after a new ...

Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

Researchers from the University of Michigan Health Rogel Cancer Center have created a urine-based test that detects pieces of DNA fragments released by head and neck tumors. The test could potentially ...

Researchers have developed a urine-based test to detect head and neck cancer, opening the door to more accessible screening. Early detection of cancer is critical as it can result in better outcomes ...

A mouthwash-based biomarker test has demonstrated efficacy for detecting risk of head and neck cancer recurrence, according to results of a nonrandomized clinical trial. A multi-institutional team of ...

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for ...